Iris Diagnostics launches urine analysers in Canada
This article was originally published in Clinica
Executive Summary
Urinalysis specialist Iris Diagnostics has launched its iQ200 Elite urine microscopy analysers to one of the largest clinical reference laboratories in Canada. The device uses digital imaging and Iris's auto-particle recognition software to classify urine particles into 12 categories and report the quantities of these particles in the sample. It is designed to save time by automating specimen preparation and image recognition and interpretation. Automated flow imaging analysis also provides a visual result as is found in standard microscopic analysis. The laboratory purchased the units from ESBE Scientific, Iris' Canadian distributor. Iris Diagnostics, based in Chatsworth, California, is a division of Iris International.
You may also be interested in...
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.